JP2018516229A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018516229A5 JP2018516229A5 JP2017546779A JP2017546779A JP2018516229A5 JP 2018516229 A5 JP2018516229 A5 JP 2018516229A5 JP 2017546779 A JP2017546779 A JP 2017546779A JP 2017546779 A JP2017546779 A JP 2017546779A JP 2018516229 A5 JP2018516229 A5 JP 2018516229A5
- Authority
- JP
- Japan
- Prior art keywords
- dsba
- polypeptide
- antibody
- sample
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562129701P | 2015-03-06 | 2015-03-06 | |
| US62/129,701 | 2015-03-06 | ||
| PCT/US2016/021059 WO2016144824A1 (en) | 2015-03-06 | 2016-03-04 | Ultrapurified dsba and dsbc and methods of making and using the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021001186A Division JP7191132B2 (ja) | 2015-03-06 | 2021-01-07 | 超精製ＤｓｂＡ及びＤｓｂＣ、ならびにそれらの作製及び使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018516229A JP2018516229A (ja) | 2018-06-21 |
| JP2018516229A5 true JP2018516229A5 (enExample) | 2019-04-11 |
| JP6865689B2 JP6865689B2 (ja) | 2021-04-28 |
Family
ID=55637452
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017546779A Active JP6865689B2 (ja) | 2015-03-06 | 2016-03-04 | 超精製ＤｓｂＡ及びＤｓｂＣ、ならびにそれらの作製及び使用方法 |
| JP2021001186A Active JP7191132B2 (ja) | 2015-03-06 | 2021-01-07 | 超精製ＤｓｂＡ及びＤｓｂＣ、ならびにそれらの作製及び使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021001186A Active JP7191132B2 (ja) | 2015-03-06 | 2021-01-07 | 超精製ＤｓｂＡ及びＤｓｂＣ、ならびにそれらの作製及び使用方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US10073098B2 (enExample) |
| EP (2) | EP3636749B1 (enExample) |
| JP (2) | JP6865689B2 (enExample) |
| KR (1) | KR20170122216A (enExample) |
| CN (1) | CN107531749A (enExample) |
| AR (1) | AR103852A1 (enExample) |
| AU (1) | AU2016230018A1 (enExample) |
| CA (1) | CA2978256A1 (enExample) |
| ES (1) | ES2761726T3 (enExample) |
| HK (1) | HK1247936A1 (enExample) |
| HR (1) | HRP20192217T1 (enExample) |
| IL (1) | IL254166A0 (enExample) |
| MX (2) | MX387454B (enExample) |
| PL (1) | PL3265557T3 (enExample) |
| SG (2) | SG11201707186YA (enExample) |
| SI (1) | SI3265557T1 (enExample) |
| WO (1) | WO2016144824A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| US9725710B2 (en) | 2014-01-08 | 2017-08-08 | Flodesign Sonics, Inc. | Acoustophoresis device with dual acoustophoretic chamber |
| ES2761726T3 (es) | 2015-03-06 | 2020-05-20 | Hoffmann La Roche | DsbA y DsbC ultrapurificadas y procedimientos de preparación y uso de las mismas |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| JP2021507561A (ja) | 2017-12-14 | 2021-02-22 | フロデザイン ソニックス， インク．Ｆｌｏｄｅｓｉｇｎ Ｓｏｎｉｃｓ， Ｉｎｃ． | 音響トランスデューサドライバ及びコントローラ |
| TWI870412B (zh) * | 2019-06-05 | 2025-01-21 | 美商建南德克公司 | 過載層析管柱之再生方法 |
| MX2022011780A (es) | 2020-04-09 | 2022-11-10 | Cytomx Therapeutics Inc | Composiciones que contienen anticuerpos activables. |
| US12540929B2 (en) * | 2021-12-17 | 2026-02-03 | Dionex Corporation | Desalting system for chromatography |
| CN115028691B (zh) * | 2022-06-29 | 2024-09-10 | 青岛硕景生物科技有限公司 | 一种检测试纸用的独立质控系统、杂交瘤细胞株、质控线用包被单克隆抗体及其应用 |
| CN119874933A (zh) * | 2024-11-20 | 2025-04-25 | 金宇保灵生物药品有限公司 | 一种基于大肠杆菌的纳米抗体融合表达体系及其制备方法 |
Family Cites Families (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2046920B1 (enExample) | 1969-06-19 | 1974-05-03 | Citizen Watch Co Ltd | |
| US3691016A (en) | 1970-04-17 | 1972-09-12 | Monsanto Co | Process for the preparation of insoluble enzymes |
| US3940475A (en) | 1970-06-11 | 1976-02-24 | Biological Developments, Inc. | Radioimmune method of assaying quantitatively for a hapten |
| CA1023287A (en) | 1972-12-08 | 1977-12-27 | Boehringer Mannheim G.M.B.H. | Process for the preparation of carrier-bound proteins |
| US4195128A (en) | 1976-05-03 | 1980-03-25 | Bayer Aktiengesellschaft | Polymeric carrier bound ligands |
| US4330440A (en) | 1977-02-08 | 1982-05-18 | Development Finance Corporation Of New Zealand | Activated matrix and method of activation |
| CA1093991A (en) | 1977-02-17 | 1981-01-20 | Hideo Hirohara | Enzyme immobilization with pullulan gel |
| US4229537A (en) | 1978-02-09 | 1980-10-21 | New York University | Preparation of trichloro-s-triazine activated supports for coupling ligands |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4737456A (en) | 1985-05-09 | 1988-04-12 | Syntex (U.S.A.) Inc. | Reducing interference in ligand-receptor binding assays |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5508192A (en) | 1990-11-09 | 1996-04-16 | Board Of Regents, The University Of Texas System | Bacterial host strains for producing proteolytically sensitive polypeptides |
| US5264365A (en) | 1990-11-09 | 1993-11-23 | Board Of Regents, The University Of Texas System | Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides |
| US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
| EP0940468A1 (en) | 1991-06-14 | 1999-09-08 | Genentech, Inc. | Humanized antibody variable domain |
| MX9204374A (es) | 1991-07-25 | 1993-03-01 | Idec Pharma Corp | Anticuerpo recombinante y metodo para su produccion. |
| EP0604580A1 (en) | 1991-09-19 | 1994-07-06 | Genentech, Inc. | EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES |
| FI941572L (fi) | 1991-10-07 | 1994-05-27 | Oncologix Inc | Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| JPH07501451A (ja) | 1991-11-25 | 1995-02-16 | エンゾン・インコーポレイテッド | 多価抗原結合タンパク質 |
| DE69333807T2 (de) | 1992-02-06 | 2006-02-02 | Chiron Corp., Emeryville | Marker für krebs und biosynthetisches bindeprotein dafür |
| DE69308573T2 (de) | 1992-08-17 | 1997-08-07 | Genentech Inc | Bispezifische immunoadhesine |
| GB9325718D0 (en) * | 1993-12-16 | 1994-02-16 | Ars Holding 89 Nv | Sensor device for sandwich assay |
| US5639635A (en) * | 1994-11-03 | 1997-06-17 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US6027888A (en) | 1996-04-05 | 2000-02-22 | Board Of Regents, The University Of Texas System | Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells |
| US6083715A (en) | 1997-06-09 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
| JP2000083670A (ja) * | 1998-09-09 | 2000-03-28 | Hsp Kenkyusho:Kk | ＤｓｂＡ／ＤｓｂＢ／ＤｓｂＣ／ＤｓｂＤ発現プラスミド |
| IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
| CA2364568A1 (en) * | 1999-03-17 | 2000-09-21 | Adrian Woolfson | Method for refolding molecules of polypeptides containing ig domains |
| US6872563B1 (en) * | 1999-10-05 | 2005-03-29 | President And Fellows Of Harvard College | Compositions and methods for production of disulfide bond containing proteins in host cells |
| ES2637801T3 (es) | 2000-04-11 | 2017-10-17 | Genentech, Inc. | Anticuerpos multivalentes y usos de los mismos |
| MXPA03005273A (es) | 2000-12-14 | 2003-09-25 | Genentech Inc | Anticuerpos producidos procarioticamente y sus usos. |
| EP1345967B1 (en) | 2000-12-22 | 2011-08-10 | Grad, Carole, Legal representative of Kaplan, Howard | Phage display libraries of human v h fragments |
| JP2005289809A (ja) | 2001-10-24 | 2005-10-20 | Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) | 突然変異重鎖抗体 |
| SI1639011T1 (sl) | 2003-06-30 | 2009-04-30 | Domantis Ltd | Pegilirana protitelesa z enojno domeno (dAb) |
| KR100956913B1 (ko) | 2003-12-19 | 2010-05-11 | 제넨테크, 인크. | 치료제로서 유용한 일가 항체 단편 |
| KR101270829B1 (ko) | 2004-09-23 | 2013-06-07 | 제넨테크, 인크. | 시스테인 유전자조작 항체 및 접합체 |
| CN100475965C (zh) | 2005-07-22 | 2009-04-08 | 上海高科联合生物技术研发有限公司 | 一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法 |
| EP2035456A1 (en) | 2006-06-22 | 2009-03-18 | Novo Nordisk A/S | Production of bispecific antibodies |
| EP2059533B1 (en) | 2006-08-30 | 2012-11-14 | Genentech, Inc. | Multispecific antibodies |
| MX2009007632A (es) * | 2007-01-22 | 2009-07-24 | Genentech Inc | Precipitacion de polielectrolito y purificacion de proteinas. |
| SI2235064T1 (sl) | 2008-01-07 | 2016-04-29 | Amgen Inc. | Metoda za izdelavo heterodimernih molekul - protitelesa fc z uporabo elektrostatičnih usmerjevalnih učinkov |
| CN105274170A (zh) * | 2009-11-05 | 2016-01-27 | 弗·哈夫曼-拉罗切有限公司 | 分泌异源多肽的方法和组合物 |
| AU2010201410B2 (en) * | 2010-03-30 | 2015-04-30 | Pelican Technology Holdings, Inc. | High level expression of recombinant CRM197 |
| GB201012519D0 (en) | 2010-07-26 | 2010-09-08 | Ucl Business Plc | Method and system for anomaly detection in data sets |
| GB201012599D0 (en) * | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Process for purifying proteins |
| MX2014005330A (es) * | 2011-11-02 | 2014-09-08 | Genentech Inc | Cromatografia de sobrecarga y elucion. |
| SG10202108497TA (en) * | 2013-04-19 | 2021-09-29 | Sutro Biopharma Inc | Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones |
| KR102332302B1 (ko) * | 2013-09-13 | 2021-12-01 | 제넨테크, 인크. | 세포주에서 숙주 세포 단백질 및 재조합 폴리펩티드 생성물을 검출 및 정량화하기 위한 조성물 및 방법 |
| ES2761726T3 (es) | 2015-03-06 | 2020-05-20 | Hoffmann La Roche | DsbA y DsbC ultrapurificadas y procedimientos de preparación y uso de las mismas |
-
2016
- 2016-03-04 ES ES16712126T patent/ES2761726T3/es active Active
- 2016-03-04 CN CN201680026013.3A patent/CN107531749A/zh active Pending
- 2016-03-04 AU AU2016230018A patent/AU2016230018A1/en not_active Abandoned
- 2016-03-04 SI SI201630544T patent/SI3265557T1/sl unknown
- 2016-03-04 HR HRP20192217TT patent/HRP20192217T1/hr unknown
- 2016-03-04 JP JP2017546779A patent/JP6865689B2/ja active Active
- 2016-03-04 WO PCT/US2016/021059 patent/WO2016144824A1/en not_active Ceased
- 2016-03-04 MX MX2021000153A patent/MX387454B/es unknown
- 2016-03-04 US US15/061,943 patent/US10073098B2/en active Active
- 2016-03-04 PL PL16712126T patent/PL3265557T3/pl unknown
- 2016-03-04 AR ARP160100573A patent/AR103852A1/es not_active Application Discontinuation
- 2016-03-04 EP EP19195777.8A patent/EP3636749B1/en active Active
- 2016-03-04 HK HK18107289.5A patent/HK1247936A1/zh unknown
- 2016-03-04 EP EP16712126.8A patent/EP3265557B1/en active Active
- 2016-03-04 SG SG11201707186YA patent/SG11201707186YA/en unknown
- 2016-03-04 SG SG10202005917SA patent/SG10202005917SA/en unknown
- 2016-03-04 KR KR1020177026459A patent/KR20170122216A/ko not_active Ceased
- 2016-03-04 CA CA2978256A patent/CA2978256A1/en not_active Abandoned
- 2016-03-04 MX MX2017011189A patent/MX381844B/es unknown
-
2017
- 2017-08-27 IL IL254166A patent/IL254166A0/en unknown
-
2018
- 2018-07-24 US US16/044,360 patent/US10690671B2/en active Active
-
2021
- 2021-01-07 JP JP2021001186A patent/JP7191132B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018516229A5 (enExample) | ||
| HRP20192217T1 (hr) | ULTRA-PROČIŠĆENI DsbA I DsbC TE POSTUPCI NJIHOVE IZRADE I UPORABE | |
| US10246484B2 (en) | Method for purifying recombinant protein | |
| Tarrant et al. | Host cell protein adsorption characteristics during protein A chromatography | |
| Gagnon et al. | Nonspecific interactions of chromatin with immunoglobulin G and protein A, and their impact on purification performance | |
| US20120283419A1 (en) | Separation of protein monomers from aggregates by solid weak anion exchange support functionalized with amine moieties | |
| Nfor et al. | Multi‐dimensional fractionation and characterization of crude protein mixtures: toward establishment of a database of protein purification process development parameters | |
| JP2015503524A5 (enExample) | ||
| EP2326658A1 (en) | Enhanced protein aggregate removal with multimodal anion exchangers in the presence of protein-excluded zwitterions | |
| CN107849541A (zh) | 纯化腺病毒载体的方法 | |
| CN115135339A (zh) | 一种从完整的aav衣壳中分离或去除空的aav衣壳的方法 | |
| JP2017519838A (ja) | タンパク質の精製のための方法及び試薬 | |
| KR20220079910A (ko) | 숙주-세포 단백질을 특성화하는 방법 | |
| RU2018121653A (ru) | Улучшенное разделение белков при ионообменной хроматографии | |
| Grönberg | Ion exchange chromatography | |
| De Vos et al. | Production of full-length SARS-CoV-2 nucleocapsid protein from Escherichia coli optimized by native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection | |
| Kröner et al. | Analytical characterization of complex, biotechnological feedstocks by pH gradient ion exchange chromatography for purification process development | |
| JP7320121B2 (ja) | 眼科用タンパク質医薬品の精製方法（Ｒｅｆｉｎｉｎｇ ｍｅｔｈｏｄ ｏｆ ｏｐｈｔｈａｌｍｉｃ ｐｒｏｔｅｉｎ ｐｈａｒｍａｃｅｕｔｉｃａｌｓ） | |
| CN113166732A (zh) | 使用亲和色谱法的用于疫苗病毒的纯化方法 | |
| Morrison et al. | Purification of monomeric mAb from associated aggregates using selective desorption chromatography in hydroxyapatite systems | |
| Giacometti et al. | Protein and peptide separations | |
| Chen et al. | Partition coefficient screening–An effective approach for finding the best conditions for byproduct removal as demonstrated by a bispecific antibody purification case | |
| Caramelo-Nunes et al. | Dynamic binding capacity and specificity of 3, 8-diamino-6-phenylphenanthridine-Sepharose support for purification of supercoiled plasmid deoxyribonucleic acid | |
| Chen et al. | Resin and loading condition screening for effective and robust byproducts removal by anion exchange chromatography: a case study | |
| Bicho et al. | Application of ethylenediamine monolith to purify a hemagglutinin influenza deoxyribonucleic acid-based vaccine |